Pancreatic Cancer

  • RTOG 0848 (SOMC Pending)– Phase III Trial Evaluating both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma (Arm 2 Closed to Accrual)
  • SWOG S1505– A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/Nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma (Temporarily closed)
  • ECOG EA2142– A Randomized Phase II Study of Cisplatin and Etoposide versus Temozolomide and Capecitabine in Patients with Advanced G3 Non-Small Cell Gastroenteropanceatic Neuroendocrine Carcinomas